From furthering electric vehicle adoption to developing new therapies for cancer treatments, Boston innovators have been hard at work. Learn more about what these companies have been building with the Built In Boston Weekly Refresh.
1upHealth pulled in $40M. Backed by a Series C round of capital led by Sixth Street Growth, 1upHealth plans to expand its product development and customer growth teams. The company operates a cloud-based data platform that works to help enterprises such as regional health plans acquire, store and interact with the data they need to power their business operations and analytics. 1upHealth is also hiring for a handful of roles. [Business Wire]
.406 Ventures raised $244M. The Boston-based VC firm pulled in a new cash injection as part of its fifth fund. The firm invests in early-stage companies focused on the cybersecurity, digital health and data and cloud sectors of the tech industry. This latest capital raise follows .406 Venture’s prior round in 2019 which closed its fourth fund with $294 million. [Boston Business Journal]
Boston Tech Quote of the Week
“I founded MoveEV to help everyday Americans get into electric cars and reap their benefits. Environmental justice communities are disproportionately harmed by local air pollution from Internal Combustion Engine vehicles, and I feel called to make sure these communities get the funding and programs they need to transition from gas-powered vehicles to electric.” — David Lewis, CEO and co-founder of MoveEV
MoveEV announced plans to lead a clean energy task force. MoveEV developed an HR benefit platform that works to help employees transition to electric vehicles. Its tech helps users understand their vehicle’s economic and environmental costs, It also informs them of government incentives for EV adoption. MoveEV will lead the task force for the Advanced Energy Group’s Boston Stakeholder Challenge. The task force will work to identify and remove roadblocks to EV adoption in environmental justice communities. [GlobeNewswire]
BPGbio partnered with the U.S. Department of Defense. Headquartered in Framingham, BPGbio is a biotech company developing drug therapies for conditions like pancreatic cancer and chemotherapy-induced alopecia. BPGbio developed its prostate-cancer test in partnership with the U.S. Department of Defense. In a new five-year agreement, the two entities will work to develop a breast cancer test. [Boston Business Journal]
